Sign up
Pharma Capital

eSense-Lab develops e-liquid formulation with cannabis aroma

eSense is aiming to commercialise its formulations into the global e-cigarette liquid market.
Vaping is a safer and healthier alternative to smoking cannabis

eSense-Lab Ltd (ASX:ESE) has completed the development of an e-liquid formulation that provides the aroma of various cannabis strains.

E-liquids are liquids used for vaporising and are manufactured using either propylene glycol (PG), vegetable glycerine (VG), or a combination of both.

Vaporising (or vaping) is a safer and healthier alternative to smoking cannabis. Nicotine can also be added, along with an endless number of flavours.

READ: eSense-Lab reveals robust antioxidant activity for its medical cannabis terpenes

Over the last several months, eSensehas researched several e-liquid formulations incorporated with natural terpene blends grounded on the profile base of various cannabis strains.

These e-liquids were formulated using natural PG/VG blended in an accepted ratio and reinforced with naturally derived cannabis-like terpenes of strains such as Granddaddy Purple, Gorilla Glue and OG-Kush.

eSense chief executive officer Haim Cohen said: "This step forward in our techno-marketing efforts, is an important one, as it places eSense, with its proprietary knowledge and formulations, in the forefront of the E-liquid market.

"The overall mission of eSense's is to commercialise our formulations and products into the e-cigarette liquid market globally, and in my opinion, this new formulation will assist eSense on the company’s road to achieving commercial success in the future."

Register here to be notified of future ESE Company articles
View full ESE profile View Profile
View All

Related Articles

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.